ÇETİN, B. Et Al. 2017. Hepatotoxicity of vascular endothelial growth factor receptortyrosine kinase inhibitors: clinical practice and evidence. Drugs Therapy Perspectives .

ÇETİN, B., Bilgetekin, I., CENGİZ, M., & ÖZET, A., (2017). Hepatotoxicity of vascular endothelial growth factor receptortyrosine kinase inhibitors: clinical practice and evidence. Drugs Therapy Perspectives .

ÇETİN, BÜLENT Et Al. "Hepatotoxicity of vascular endothelial growth factor receptortyrosine kinase inhibitors: clinical practice and evidence," Drugs Therapy Perspectives , 2017

ÇETİN, BÜLENT Et Al. "Hepatotoxicity of vascular endothelial growth factor receptortyrosine kinase inhibitors: clinical practice and evidence." Drugs Therapy Perspectives , 2017

ÇETİN, B. Et Al. (2017) . "Hepatotoxicity of vascular endothelial growth factor receptortyrosine kinase inhibitors: clinical practice and evidence." Drugs Therapy Perspectives .

@article{article, author={BÜLENT ÇETİN Et Al. }, title={Hepatotoxicity of vascular endothelial growth factor receptortyrosine kinase inhibitors: clinical practice and evidence}, journal={Drugs Therapy Perspectives}, year=2017}